Kane Biotech Presents revyve® Clinical Data at Symposium on Advanced Wound Care (SAWC) Spring Conference

Stock Information for Kane Biotech Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Kane Biotech Inc.

Kane Biotech Announces Fourth Quarter and Full Year 2025 Financial Results
Kane Biotech Announces Publication in Frontiers in Antibiotics Highlighting Advancements in Treating Antibiotic Tolerant Biofilms
Kane Biotech Expands U.S. Commercial Footprint with Strategic Distribution Partnership
Kane Biotech Announces Publication of revyve® Wound Gel Article in the International Wound Journal
Kane Biotech Expands Commercial Activities in the United States
Kane Biotech Announces FDA 510(k) Clearance for revyve® Antimicrobial Skin and Wound Cleanser
Kane Biotech Restarts Commercial Activities and Strengthens North American Management
Kane Biotech Announces Closing of Private Placement Offering with an Insider of the Company

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.